Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000905

Type of data
NGS (Exome, RNA-seq)
Access criteria
Controlled-access (Type I)
Total data volume
520 GB
File formats
  • FASTQ
Research
hum0483
Date published
2025-06-11
Date modified
2025-12-11
DDBJ Search
JGAD000905 (opens in a new tab)
JGA Study
JGAS000764 (opens in a new tab)

Analysis method

WES

Materials and participants
Ovarian clear cell carcinoma (ICD10: C56): 11 cases
tumor-derived organoid: 11 samples
normal tissue: 11 samples
  • Health status
    Affected
  • Subject count
    11 (Individual)
Disease
Ovarian clear cell carcinoma (C56)
Sample description
DNA extracted from tumor-derived organoids and normal tissue from peripheral blood mononuclear cells
  • Tissue
    Organoid, PBMC, Peripheral blood
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
WES
Target
N/A
Reagent kit
xGen Exome Research Panel
Fragmentation
Enzymatic fragmentation
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
150 bp
Data use policy
NBDC data sharing policy (JGAP000001)

RNA-seq

Materials and participants
Ovarian clear cell carcinoma (ICD10: C56): 10 cases
tumor-derived organoid: 10 samples
AGR2 knockout clear cell carcinoma organoid: 4 samples
GFP overexpressed clear cell carcinoma organoide: 2 samples
High-grade serous carcinoma (ICD10: C56): 7 cases
tumor-derived organoid: 7 samples
  • Health status
    Affected
  • Subject count
    17 (Individual)
Disease
Ovarian clear cell carcinoma (C56)
High-grade serous carcinoma (C56)
Sample description
RNA extracted from tumor-derived organoids
  • Tissue
    Organoid
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
TruSeq RNA Exome
Fragmentation
Heat treatment
Platform
Illumina HiSeq X
Illumina NovaSeq 6000
MGI DNBSEQ-G400
Read type
Paired-end
Read length
150 bp
Data use policy
NBDC data sharing policy (JGAP000001)